Interactions between Xenobiotics and DME (XEOTIC)
|
Fungicide(s), Herbicide(s) or Insecticide(s) |
Herbicide |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Atrazine |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00969
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Herbicide |
DME Modulation |
Atrazine up-regulates the expression of DME FAAH |
[1] |
Health or Environmental Toxicant(s) |
Carcinogen |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Benzo(a)pyrene |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00898
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Carcinogen |
DME Modulation |
Benzo(a)pyrene up-regulates the expression of DME FAAH |
[2] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Acetaminophen |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00217
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Acetaminophen up-regulates the expression of DME FAAH |
[3] |
Progesterone |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00094
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Progesterone induces the drug-metabolizing activity of DME FAAH |
[4] |
Valproic acid |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00029
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Drug Approved by US FDA |
DME Modulation |
Valproic acid inhibits the expression of DME FAAH |
[5] |
Drug in Phase 2 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 2 Xenobiotics
|
4-phenylbutyric acid |
Click to Show/Hide the Detail |
Induction |
XEOTIC ID |
XEO00584
XEOTIC Info
|
Gene Form |
mRNA |
Classification |
Highest Clinical Status: Phase 2/3 |
DME Modulation |
4-phenylbutyric acid up-regulates the expression of DME FAAH |
[6] |
Bisphenol A |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01226
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 2 |
DME Modulation |
Bisphenol A inhibits the drug-metabolizing activity of DME FAAH |
[7], [8] |
Drug in Phase 1 Clinical Trial |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
URB-597 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00639
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Highest Clinical Status: Phase 1 |
DME Modulation |
URB-597 inhibits the drug-metabolizing activity of DME FAAH (IC50 = 0.00024 microM) |
[9] |
Preclinical/Patented Drug |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
RHC-80267 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO01092
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug in Preclinical Study |
DME Modulation |
RHC-80267 inhibits the drug-metabolizing activity of DME FAAH in Human embryonic kidney 293 cell (HEK293T) (IC50 = 70 microM) |
[10] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Butylparaben |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00930
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
Butylparaben inhibits the drug-metabolizing activity of DME FAAH |
[11] |
Other Chemical Compound(s) or Element(s) |
Food Additive |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Heptylparaben |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00932
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Food Additive |
DME Modulation |
Heptylparaben inhibits the drug-metabolizing activity of DME FAAH |
[11] |
|
|
|
|
|
|